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Circular RNAs are new players in regulation of post transcriptional gene expression. Animal
genomes express many circular RNAs from diverse genomic locations. A recent study
has validated a fairly large number of circular RNAs in human, mouse, and nematode.
Circular RNAs play a crucial role in fine tuning the level of miRNA mediated regulation of
gene expression by sequestering the miRNAs. Their interaction with disease associated
miRNAs indicates that circular RNAs are important for disease regulation. In this paper we
studied the potential association of circular RNAs (circRNA) with human diseases in two
different ways. Firstly, the interactions of circRNAs with disease associated miRNAs were
identified, following which the likelihood of a circRNA being associated with a disease was
calculated. For the miRNAs associated with individual diseases, we constructed a network
of predicted interactions between the miRNAs and protein coding, long non-coding and
circular RNA genes. We carried out gene ontology (GO) enrichment analysis on the set of
protein coding genes in the miRNA- circRNA interactome of individual diseases to check
the enrichment of genes associated with particular biological processes. Secondly, disease
associated SNPs were mapped on circRNA loci, and Argonaute (Ago) interaction sites on
circular RNAs were identified. We compiled a database of disease-circRNA association
in Circ2Traits (http://gyanxet-beta.com/circdb/), the first comprehensive knowledgebase of
potential association of circular RNAs with diseases in human.
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INTRODUCTION
Circular RNAs, formed by covalent linkage of the ends of a single
RNA molecule, are newly discovered RNAs that sponge miRNAs
to block their function (Memczak et al., 2013). These circular
transcripts were previously thought to be scarcely expressed until
recently, when thousands of circular RNA transcripts were iden-
tified in both human and mouse by two independent studies by
Jeck et al. (2013) and Memczak et al. (2013). Like the previously
reported circular RNAs in archea (Grabowski et al., 1981), unicel-
lular organisms (Tetrahymena thermophila) (Danan et al., 2012)
and plants (Sanger et al., 1976), animal genomes abundantly
express many circular RNAs from diverse genomic locations, such
as coding and non-coding exons, intergenic regions or transcripts
antisense to 5′ and 3′UTRs (Jeck et al., 2013). In the study by Jeck
et al. (2013), circular RNAs were identified by high throughput
sequencing of the ribosome-depleted fraction of RNA treated by
RNase R (RNase R exonuclease degrades linear RNAs but leaves
circRNAs unaffected), combined with a bioinformatic algorithm.
Memczak et al have identified 2000 human, 1900 mouse, and
700 nematode circular RNAs from sequencing data (Memczak
et al., 2013). A number of the identified circular RNAs were fur-
ther experimentally tested by Memczak et al in HEK293 cells.
Often the expressions of these circular RNAs show tissue speci-
ficity or even specificity to developmental stages. A study by
Capel et al found circular RNA in Sex Determining Region Y
(SRY) which is highly expressed in testes (Capel et al., 1993).
Circular non-polyadenylated RNA molecules have been identi-
fied as stable transcription products of the human ETS-1 and
mouse Sry genes (Dubin et al., 1995). Jeck et al suggested that
endogenous circular RNAs are abundant, stable, conserved and
non-random products of RNA splicing andmay have roles to play
in control of gene expression. Using high-throughput sequenc-
ing libraries they have identified more than 25,000 distinct RNA
species in human fibroblasts that contain non-collinear exons and
were reproducibly enriched by exonuclease degradation of linear
RNA (Jeck et al., 2013).
The fact that circular RNAs are targeted by endogenous
miRNAs was reported by Hansen et al. The authors outlined
a circRNA destruction mechanism in which miR-671 binds
CDR1as/ciRS-7 with greater complementarities than miR-7 and
induces cleavage of this circRNA mediated by Ago [the catalytic
component of RNA induced silencing complex (RISC) which
is a central component of RNA interference (RNAi) machin-
ery] (Hansen et al., 2011). Furthermore, it has recently come
to light that these circular RNAs play a critical role in fine-
tuning the level of miRNAmediated regulation of gene expression
by sequestering the miRNAs. A study has identified a highly
expressed endogenous circular RNA (circRNA) in human brain
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and mouse brain and has demonstrated that the circRNA in
Cerebellar Degeneration Related protein 1 (CDR1) locus can be
endonucleolytically cleaved by miR-671 in an Ago2- dependent
manner (Hansen et al., 2011, 2013a,b). This phenomenon leads
to decrease in CDR1 mRNA levels independently of heterochro-
matin formation.
Owing to their ability for sequestration of miRNAs,
circular RNAs play an important role in fine tuning of
post-transcriptional gene expression. From their interaction
with disease associated miRNAs, we surmise they have a potential
role in disease regulation. In the study by Hansen et al. (2011),
the circRNA CDR1as, which is the antisense transcript of
CDR1, has been identified to be targeted by miR-7, a miRNA
implicated in various disease, including Parkinson’s disease and
several types of cancers. Importantly, the circRNA CDR1as
was seen to be frequently expressed in many tumor cell lines
including neuroblastoma (widespread expression), renal cell,
and lung carcinomas (Hansen et al., 2013a,b). Its expression
was primarily found in the brain where it was co-expressed with
miR-7 (Hansen et al., 2011). In the current paper we studied
the potential association of circular RNAs with human diseases
by two different approaches. Firstly, we studied the potential
interactions of circular RNAs with disease associated miRNAs
and constructed the interactome network (comprising of protein
coding, non-coding, and circular RNA genes) of miRNAs associ-
ated with individual diseases. We implemented a measure for the
likelihood of a circRNA to be associated with a disease in terms
of the statistical significance of the circRNA’s interaction with
miRNAs associated with the concerned disease. Gene ontology
(GO) enrichment analysis was performed on the set of protein
coding genes in the miRNA-circRNA interactome of diseases
to check the enrichment of genes associated with particular
biological processes. Secondly, we focussed on disease and traits
associated variations in the circular RNA loci and also mapped
Ago interaction sites within circular RNA loci. We compiled a
database Circ2Traits, the first comprehensive knowledgebase
for potential association of circular RNAs with diseases in
human.
MATERIALS AND METHODS
DATA SOURCE
We used the circular RNA dataset from Memczak et al.
(2013). This dataset consists of 1953 predicted human circu-
lar RNAs along with their genomic coordinates, annotation,
and predicted miRNA seed matches. Disease related miRNA
data was taken from miR2disease (Jiang et al., 2009) to
check the association of circular RNAs with disease associ-
ated miRNAs. miR2Disease currently stores curated information
about human miRNAs associated with 174 different diseases
in human. From Starbase (Yang et al., 2011) we collected the
miRNA-mRNA interaction data predicted by MiRanda (Enright
et al., 2003), TargetScan (Grimson et al., 2007), PiTA (Kertesz
et al., 2007), PicTar (Krek et al., 2005), and RNA22 (Miranda
et al., 2006) that mapped to the Ago interacting regions. Dataset
for predicted miRNA and long non-coding RNA interaction
pairs was collected from miRCode database (Jeggari et al.,
2012).
CALCULATING THE LIKEHOOD OF circRNAs TO BE ASSOCIATED WITH
DISEASES
We implemented a measure for the likelihood of a circRNA
to be associated with a disease in terms of the significance of
the circRNA’s interaction with miRNAs associated with the con-
cerned disease. We calculated p-values for disease association of
each circRNAs interacting with disease associated miRNAs. We
conducted hypergeometric test using the following parameters:
i. number of disease associated miRNAs interacting with the
circRNA against the total number of disease associated miR-
NAs
ii. the total number of miRNAs interacting with the circRNA
iii. the total number of human miRNAs
For each circRNA interacting with miRNAs associated with a par-
ticular disease, the p-value for the likelihood of the circRNA to be
enriched for interaction withmiRNAs associated with that disease
is calculated as:
p =
min∑
i=md
(mc,Md)
(
Md
i
)(
MT − Md
mc − i
)
(
MT
mc
) (1)
Where,
MT = Total number of miRNAs in the human genome
mc = Number of miRNAs interacting with the circRNA
Md = Total number of miRNAs associated with diseased
md = Number of miRNAs associated with disease d that
interact with the circRNA.
After applying Bonferroni correction, a circRNA with a
p-value< pthreshold is shown as likely to be associated with the
concerned disease, where,
pthreshold= 0.05/m (2)
m = Total number of circRNAs interacting with any miRNA
associated with the concerned disease.
CONSTRUCTION OF miRNA INTERACTION NETWORKS
We used the predicted mRNA, lncRNA, and circular RNA targets
of all microRNAs associated with individual diseases to construct
the networks depicting the regulation of post-transcriptional gene
expression for each of the diseases. The networks were con-
structed using cytoscape (Shannon et al., 2003) by giving as
input the miRNA-target interaction table in the standard two
column format consisting of miRNA-circRNA, miRNA-mRNA,
and miRNA-lncRNA interaction. We performed GO enrich-
ment analysis on the set of protein coding genes in the miRNA
and circRNA interactome networks of individual diseases using
GORILLA GO enrichment analysis tool (Eden et al., 2009).
IDENTIFICATION OF GWAS ASSOCIATED SNPs AND Ago INTERACTION
SITES WITHIN circRNAs
We used Ago interaction sites from Ago PAR-CLIP data from the
dataset of Hafner et al. (2010), for mapping Ago interaction sites
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within circular RNA loci. For studying variations within the cir-
cular RNA loci, we collected genome wide SNP data from dbSNP
at NCBI (Sherry et al., 2001). Traits associated SNP dataset was
collected from the GWAS catalog of NHGRI that has a total of
5807 variations associated with 540 traits (Hindorff et al., 2009).
We executed all the mappings through custom programs devel-
oped in JAVA. The web interface and database were designed in
PHP and MySQL.
RESULTS
ASSOCIATION OF CIRCULAR RNAs WITH DISEASE ASSOCIATED
miRNAs
We analyzed human disease associated miRNA data collected
for 174 diseases to find circular RNAs interacting with these
disease-associated miRNAs. For 105 diseases, including several
carcinomas and neurodegenerative diseases, we found such con-
nections with circular RNAs (see supplementary file 1). We
implemented a measure for showing the likelihood of a cir-
cRNA to be associated with a disease in terms of the signifi-
cance of the circRNA’s interaction with miRNAs associated with
the concerned disease. While searching for the potential dis-
ease associated circRNAs, the users will see only the circRNAs
with greater likelihood (measured by p-value calculated using
hypergeometric test; see the Materials and Methods section)
for the disease association (in the form of their enrichment
for interacting with miRNAs associated with the concerned dis-
ease).
To get a comprehensive picture of post transcriptional reg-
ulation in these diseases, we collected the mRNA and lncRNA
targets of the disease associated miRNAs. The mRNA targets of
human miRNAs predicted from PAR-CLIP data (Hafner et al.,
2010) by widely usedmiRNA prediction tools, such as TargetScan,
miRanda, PicTar, PITA, and RNA22 were collected from StarBase
database. This dataset is more reliable, as the predictions are lim-
ited within Ago interacting regions. Alongside mRNA targets,
miRNAs are shown to target long non-coding RNAs (lncRNAs)
and pseudogenes. These non-protein coding targets of miRNAs
also play a critical role in sequestration of miRNAs and thus limit
the level of the available cellular miRNAs for targeting other pro-
tein coding targets (Wang et al., 2010; Cesana et al., 2011; Tay
et al., 2011). Hence, for modeling the miRNAmediated post tran-
scriptional regulatory network in cells, it is important to add the
lncRNA and circRNA components along with the mRNAs. We
constructed networks for miRNA mediated post transcriptional
repression in 105 diseases those were found to be associated with
circRNAs, i.e., any of the disease associated miRNAs that was
found to have binding sites in circRNAs. The number of circR-
NAs, protein coding RNAs and lncRNAs interacting withmiRNAs
associated with individual diseases is plotted in Figure 1A (cir-
cRNAs in green, protein coding RNAs in blue and lncRNAs in
red).
Furthermore, we searched for the protein coding genes for
individual diseases that were already reported to be associated
with the diseases by different functional studies. The data for dis-
ease associated genes were collected from the Genetic Association
database (Zhang et al., 2010). The Genetic Association database
mines disease association information collected from published
papers and GWAS studies. Figure 1B shows the number of dis-
ease associated genes in our study that overlapped with the
disease associated genes in the Genetic Association database for
individual diseases.
We performedGO enrichment analysis formRNA interactome
of circRNAs for individual diseases to check if the genes associ-
ated with circRNAs are preferentially associated with particular
biological processes. We found such enrichment for biological
processes for mRNAs in 90 diseases (see supplementary file 1).
Figures 2A–D show the GO enrichments of genes associated with
breast cancer, cervical cancer, gastric cancer and oral carcinoma,
respectively.
To enhance the reliability for disease association, we provided
a filtering step where users can view only the interaction net-
works of miRNAs that have a defined and validated role in a
particular disease, i.e., not all the miRNAs with just differential
expression signatures. For instance, miR-193b is characterized
to have a defined role in breast cancer as its down-regulation
contributes to tumor progression and invasion (Li et al., 2009).
We have implemented this feature by manual curation of disease
associated miRNAs.
ASSOCIATION OF CIRCULAR RNAs WITH TRAITS ASSOCIATED SNPs
For further understanding of circRNA functions and their disease
or traits association, we looked for variations in the circRNA loci.
We mapped the loci of variations in human genomic sequence
(collected from dbSNP) into the genomic loci of circRNAs. The
average number of variations mapped into 1951 circRNA loci
was 217.13 and the frequency of variations per kilobase (kb) was
24.01. This result indicates that circRNAs are much less conserved
than the protein coding RNAs, as the frequency of variations in
circRNAs is much higher than that of the CDS (0.37 SNP per kb)
and UTR (0.46 SNP per kb) of protein coding RNAs (Bhartiya
et al., 2013). We further inspected SNPs associated with dis-
eases and traits in the circRNA loci. We found 93 unique GWAS
associated SNPs mapped into 64 out of 1951 circRNAs (data in
supplementary file 2). Average number of GWAS associated SNPs
mapped per circRNA for those 64 circRNAs was 1.828. Figure 3A
shows the number of traits associated SNPs mapped into each of
the 64 circRNAs. The GWAS associated SNPs in circRNAs include
SNPs associated with 61 different traits including several types
of cancers and neurodegenerative diseases. Figure 3B shows the
distribution of circRNAs associated with these 61 different traits.
Ago INTERACTION SITES IN THE circRNA LOCI
As circRNAs are found to predominantly function as miRNA
sponges, it is evident that their functional sites are the sites
of miRNA binding, i.e., Ago binding sites. Firstly, we mapped
the Ago binding sites from the CLIP-SEQ dataset of Hafner et
al to the circRNA loci. Among 1951 circRNAs, we found 82
circRNAs whose genomic loci overlapped with one or more Ago-
interacting regions from Hafner dataset (data in supplementary
file 3). The average number of Ago-binding sites mapped per
circRNA was 2.658. Next, we sought to find variations in the
Ago-binding sites within circRNAs. We found that among 82
circRNAs with Ago-binding sites, 49 circRNAs contain one or
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FIGURE 1 | (A) The number of mRNAs (blue), lncRNAs (red), and
circRNAs (green) interacting with miRNAs associated with individual
diseases. The number of mRNAs, lncRNAs, or circRNAs is plotted
along the Y-axis, while the X-axis shows the individual disease
names. (B) The number of genes interacting with disease associated
miRNAs (as identified in our study) that overlapped with the disease
associated genes in Genetic Association database for individual
disease.
Frontiers in Genetics | Bioinformatics and Computational Biology December 2013 | Volume 4 | Article 283 | 4
Ghosal et al. Circ2Traits: potential disease associated circRNA
FIGURE 2 | (A) The GO enrichments of genes associated with breast cancer. (B) The GO enrichments of genes associated with cervical cancer. (C) The GO
enrichments of genes associated with gastric cancer. (D) The GO enrichments of genes associated with oral cancer.
more variations in their Ago-binding sites (data in supplemen-
tary file 4). The average frequency of SNPs in Ago binding sites
on 49 circRNAs is 3.1224. Figure 3C shows the distribution of
Ago interacting sites on 82 circRNAs. We did not find any GWAS
associated SNPs mapped into the Ago-binding regions within
circRNAs.
USAGE OF circ2TRAITS
Circ2Traits (http://gyanxet-beta.com/circdb/) stores information
about circRNAs, categorized according to their potential asso-
ciation with diseases, as observed from the GWAS associated
SNPs and potential interaction with disease associated miR-
NAs. The present version of circ2Traits has categorized 1951
human circRNAs potentially associated with 105 different dis-
eases. Furthermore, circ2Traits stores the complete putative
miRNA-circRNA-mRNA-lncRNA interaction network for each
of these diseases. To begin with, the users can choose from a
directory of the 105 diseases, to view a list of circRNAs most
likely to be associated with the disease and also visualize the
interaction network and see the interaction table for each dis-
ease. There are other search options like keyword based search
for miRNAs, circRNAs, protein coding genes (symbols or mRNA
accession), and lncRNAs. Search options for GWAS traits associ-
ated circRNAs are also available. For each circRNA, information
like traits associated and other SNPs, Ago interaction sites are
stored besides general information about the circRNA (name,
locus, and interacting miRNAs). The information on individ-
ual circRNAs can be viewed upon selecting a circRNA from
the interaction table. Figure 4 shows the usage of circ2Traits
pictorially.
www.frontiersin.org December 2013 | Volume 4 | Article 283 | 5
Ghosal et al. Circ2Traits: potential disease associated circRNA
FIGURE 3 | (A) The number of traits associated SNPs mapped into each of the 64 circRNAs. (B) The distribution of circRNAs associated with these 61 different
traits. (C) The distribution of Ago interacting sites on 82 circRNAs.
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FIGURE 4 | A flow diagram showing the usage of circ2Traits database. In
the first step, users can search by either disease name, or
circRNA/miRNA/mRNA/lncRNA identifier, or traits by keyword. The results
page will show the circRNAs/miRNAs/mRNAs/lncRNAs potentially associated
with disease or traits. In the second step, further searching by particular
disease name will show the user the whole miRNA-target interaction
network for the particular disease. Searching by particular circRNA will show
the detailed information about the circRNA.
DISCUSSION
circRNAs, stable transcripts expressed from diverse genomic loca-
tions, are recently identified as important players in regulation
of cellular miRNA abundance and thus are a major component
in the miRNA-mediated post transcriptional regulatory network.
These transcripts form a hidden layer in the miRNA-mediated
gene expression regulation circuitry which needs to be uncov-
ered in order to understand the post-transcriptional regulations
in cells. Available reports suggest the circRNAs show tissue spe-
cific and developmental stage specific expressions. Their inter-
actions with miRNAs imply that possibly they are associated
with many diseases. Recent availability of a considerable num-
ber of high confidence human circRNA transcripts from RNA
Sequencing prompted us to carry out our work for categoriza-
tion of these circRNAs according to their potential involvement
with diseases. We searched for potential disease associated cir-
cRNAs by two different approaches; firstly through the predicted
interaction of circRNAs with disease associated miRNAs and sec-
ondly through the association of circRNAs with disease related
SNPs. We implemented a measure for showing the likelihood of
a circRNA to be associated with a disease in terms of the sig-
nificance of the circRNA’s interaction with miRNAs associated
with the concerned disease. While searching for the potential
disease associated circRNAs, the users will see only the circR-
NAs with greater likelihood (see the Materials and Methods
section) for possible disease association in the form of their
enrichment for interacting with miRNAs associated with the
concerned disease. Our study revealed association of circRNAs
with SNPs related to a wide range of diseases including gas-
tric, oesophageal and prostate cancers and neurodegenerative
diseases like Parkinson’s disease, Alzheimer’s disease, Multiple
sclerosis, schizophrenia among many others. Further, we checked
for variations in the functional sites within circRNAs, in the Ago-
interaction sites within them. We mapped Ago-interaction sites
from CLIP-SEQ datasets into circRNA genomic loci and searched
for variations within these sites. We developed the post transcrip-
tional regulatory network for 105 human diseases comprising
miRNAs, circRNAs, mRNAs, and lncRNAs. All these information
are compiled into the database circ2Traits, the first comprehensive
knowledgebase for potential disease association of circRNAs.
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The study by Hansen et al. (2011) revealed overlaps in expres-
sion of the circRNA CDR1as and miR-7 in mouse brain sug-
gesting that a major amount of miR-7 is attached to CDR1as
in mouse brain. Interestingly, our database identifies the cir-
cRNA CDR1as most likely to be associated with the neurologi-
cal disorder Parkinson’s disease. Parkinson’s disease results from
the degeneration of dopamine-generating cells in midbrain and
disruption of miRNA network in these cells supposedly play
a critical role in the disease pathogenesis. In neurons, miR-7
was identified as a regulator of alpha-synuclein, whose over-
expression is associated with impaired function of dopamine-
generating cells and development of Parkinson’s disease. Loss
of miR-7 in cultured Parkinson’s disease cells possibly con-
tributes to increased alpha-synuclein level (Junn et al., 2009).
Interestingly, in accordance with our predicted association of
CDR1as with Parkinson’s disease, CDR1as is mostly expressed
in brain. This illustration from our database could be impor-
tant starting point for researchers for further investigations in this
direction.
In the future versions of the database we will incorporate more
elaborate study of the binding sites for the different RNA-binding
proteins in the circRNA loci. As the field matures, and the expres-
sion levels of circRNAs become more precisely known, we hope
to include the tissue specific expression patterns of the circR-
NAs (whenever available) in our database to make it a more
comprehensive and useful tool.
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